Home Research Locations About us Organization Staff Contacts Education Login Documents IT
Projects highlights


ISTAPCA (769 views)



Fondazione Veronesi

Fondo Europeo Pesca (189 views)

 INMiND (863 views)

 PRIN (961 views)

 eHealthNet (794 views)

  Ponrec (748 views)

MFAG Grant (805 views)


 |<  < >  >| 

    Export to BibTeX    Export to EndNote

A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion (404 views) (PDF restricted 83 views)

Fontanella R, Pelagalli A, Nardelli A, D'Alterio C, Ierano C, Cerchia L, Lucarelli E, Scala S, Zannetti A

Cancer Lett (ISSN: 1872-7980electronic, 0304-3835linking), 2015 Oct 27; 370(1): 100-107.

Recent findings suggest that bone marrow-derived mesenchymal stem cells (BM-MSCs) are recruited into the microenvironment of developing tumors, where they contribute to metastatic processes. The aim of this study was to investigate the role of BM-MSCs in promoting osteosarcoma and hepatocellular carcinoma cell progression in vitro and the possible mechanisms involved in these processes. U2OS and SNU-398 are osteosarcoma and hepatocellular carcinoma cell lines, respectively, that can be induced to proliferate when cultured in the presence of BM-MSCs. To determine the effect of BM-MSCs on U2OS and SNU-398 cells, the AKT and ERK signaling pathways were investigated, and increases were observed in active P-Akt and P-Erk forms. Moreover, BM-MSCs caused an increase in tumor cell migration and invasion that was derived from the enhancement of CXCR4 levels.Thus, when tumor cells were treated with the CXCR4 antagonist AMD3100, a reduction in their migration and invasion was observed. Furthermore, a new CXCR4 inhibitor, Peptide R, which was recently developed as an anticancer agent, was used to inhibit BM-MSC-mediated tumor invasion and to overcome AMD3100 toxicity. Taken together, these results suggest that inhibiting CXCR4 impairs the cross-talk between tumor cells and BM-MSCs, resulting in reduced metastatic potential in osteosarcoma and hepatocellular carcinoma cells. © 2015 Elsevier Ireland Ltd.

Affiliations ▼
*** IBB - CNR Affiliation

Istituto di Biostrutture e Bioimmagini, CNR, Naples, Italy., Istituto di Biostrutture e Bioimmagini, CNR, Naples, Italy; Dipartimento di Scienze Biomediche Avanzate, Universita degli Studi di Napoli "Federico II", Naples, Italy., Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale", IRCCS, Naples, Italy., Istituto per l'Endocrinologia e l'Oncologia Sperimentale "G. Salvatore", CNR, Naples, Italy., Istituto Ortopedico Rizzoli, Bologna, Italy., Istituto di Biostrutture e Bioimmagini, CNR, Naples, Italy. Electronic address: antonella.zannetti@cnr.it.,

Details ▼
Impact factor: 5.621, 5-year impact factor: 4.958

Paper type: Journal Article

Keywords: Bone Marrow-Derived Mesenchymal Stem Cells (bm-Mscs), Chemokine Receptor Type 4 (cxcr4), Novel Cxcr4 Inhibitor, Tumor Invasion, Chemokine Receptor Cxcr4, Chemokine Receptor Cxcr4 Antagonist, Mitogen Activated Protein Kinase, Peptide R, Plerixafor, Unclassified Drug, Antineoplastic Activity, Article, Bone Marrow Derived Mesenchymal Stem Cell, Cancer Growth, Carcinogenesis, Cell Function, Cell Interaction, Cell Invasion, Cell Proliferation, Controlled Study, Hepatocellular Carcinoma Cell Line, Human, Human Cell, In Vitro Study, Liver Cell Carcinoma, Metastasis Potential, Migration Inhibition, Osteosarcoma, Priority Journal, Protein Phosphorylation, Signal Transduction, Snu 398 Cell Line, U2os Cell Line

Url: https://www2.scopus.com/inward/record.uri?eid=2-s2.0-84949455030&partnerID=40&md5=63010eee90601e58d27b20329e347084

References ▼
Quail, D.F., Joyce, J.A., Microenvironmental regulation of tumor progression and metastasis (2013) Nat. Med, 19, pp. 1423-143

Quante, M., Tu, S.P., Tomita, H., Gonda, T., Wang, S.S., Takashi, S., Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth (2011) Cancer Cell, 19, pp. 257-272

Barcellos-de-Souza, P., Gori, V., Bambi, F., Chiarugi, P., Tumor microenvironment: bone marrow-mesenchymal stem cells as key players (1836) Biochim. Biophys. Acta, 2013, pp. 321-335

Hanahan, D., Weinberg, R.A., Hallmarks of cancer: the next generation (2011) Cell, 144, pp. 646-674

Worthley, D.L., Si, Y., Quante, M., Churchill, M., Mukherjee, S., Wang, T.C., Bone marrow cells as precursors of the tumor stroma (2013) Exp. Cell Res, 319, pp. 1650-1656

Liu, S., Ginestier, C., Ou, S.J., Clouthier, S.G., Patel, S.H., Monville, F., Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks (2011) Cancer Res, 15, pp. 614-624

Luo, J., Ok Lee, S., Liang, L., Huang, C.K., Li, L., Wen, S., Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling (2014) Oncogene, 22, pp. 2768-2778

Chaturvedi, P., Gilkes, D.M., Wong, C.C., Kshitiz, W., Luo, W., Zhang, H., Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis (2013) J. Clin. Invest, 123, pp. 189-205

Suzuki, K., Sun, R., Origuchi, M., Kanehira, M., Takahata, T., Itoh, J., Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization (2011) Mol. Med, 17, pp. 579-587

Jung, Y., Kim, J.K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis (2013) Nat. Commun, 4, p. 1795

Shinagawa, K., Kitadai, Y., Tanaka, M., Sumida, T., Kodama, M., Higashi, Y., Mesenchymal stem cells enhance growth and metastasis of colon cancer (2010) Int. J. Cancer, 127, pp. 2323-2333

Halpern, J.L., Kilbarger, A., Lynch, C.C., Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor (2011) Cancer Lett, 308, pp. 91-99

Teicher, B.A., Fricker, S.P., CXCL12 (SDF-1)/CXCR4 pathway in cancer (2010) Clin. Cancer Res, 16, pp. 2927-2931

Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M.E., Involvement of chemokine receptors in breast cancer metastasis (2001) Nature, 410, pp. 50-56

Scala, S., Ottaiano, A., Ascierto, P.A., Cavalli, M., Simeone, E., Giuliano, P., Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma (2005) Clin. Cancer Res, 11, pp. 1835-1841

Vose, J.M., Ho, A.D., Coiffier, B., Corradini, P., Khouri, I., Sureda, A., Advance in mobilization for the optimization of autologous stem cell transplantation (2009) Leuk. Lymphoma, 50, pp. 1412-1421

Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis (2005) Stem Cells, 23, pp. 879-894

De Clercq, E., The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil) (2009) Biochem. Pharmacol, 77, pp. 1655-1664

Hendrix, C.W., Collier, A.C., Lederman, M.M., Schols, D., Pollard, R.B., Brown, S., Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection (2004) J. Acquir. Immune Defic. Syndr, 37, pp. 1253-1262

Portella, L., Vitale, R., De Luca, S., D'Alterio, C., Ieranò, C., Napolitano, M., Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases (2013) PLoS ONE, 8, p. 9

Tu, B., Du, L., Fan, Q.M., Tang, Z., Tang, T.T., STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma (2012) Cancer Lett, 325, pp. 80-88

Xu, W.T., Bian, Z.Y., Fan, Q.M., Li, G., Tang, T.T., Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis (2009) Cancer Lett, 281, pp. 32-41

Zhang, P., Dong, L., Yan, K., Long, H., Yang, T.T., Dong, M.Q., CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF (2013) Oncol. Rep, 30, pp. 1753-1761

Yu, F.X., Hu, W.J., He, B., Zheng, Y.H., Zhang, Q.Y., Chen, L., Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion (2015) World J. Surg. Oncol, 13, p. 52

Li, X., Luo, Q., Sun, J., Song, G., Conditioned medium from mesenchymal stem cells enhances the migration of hepatoma cells through CXCR4 up-regulation and F-actin remodeling (2015) Biotechnol. Lett, 37, pp. 511-521

Li, T., Zhao, S., Song, B., Wei, Z., Lu, G., Zhou, J., Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma (2015) Eur. J. Med. Res, 20, p. 56

Clark, J.C., Dass, C.R., Choong, P.F., A review of clinical and molecular prognostic factors in osteosarcoma (2008) J. Cancer Res. Clin. Oncol, 134, pp. 281-297

Ghanem, I., Riveiro, M.E., Paradis, V., Faivre, S., de Parga, P.M., Raymond, E., Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis (2014) Am. J. Transl. Res, 6, pp. 340-352

Pierini, M., Dozza, B., Lucarelli, E., Tazzari, P.L., Ricci, F., Remondini, D., Efficient isolation and enrichment of mesenchymal stem cells from bone marrow (2012) Cytotherapy, 14, pp. 686-693

Zannetti, A., Iommelli, F., Fonti, R., Papaccioli, A., Sommella, J., Lettieri, A., Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3 (2008) Clin. Cancer Res, 15, pp. 5209-5219

Zannetti, A., Del Vecchio, S., Carriero, M.W., Fonti, R., Franco, P., Botti, G., Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma (2000) Cancer Res, 15, pp. 1546-1551

Scala, S., Molecular pathways: targeting the CXCR4-CXCL12 axis-untapped potential in the tumor microenvironment (2015) Clin. Cancer Res, 21, pp. 4278-4285

Ieranò, C., Santagata, S., Napolitano, M., Guardia, F., Grimaldi, A., Antignani, E., CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells (2014) Cell Death Dis, 5, p. e1310

Koh, B.I., Kang, Y., The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells (2012) EMBO Rep, 13, pp. 412-422

Bergfeld, S.A., DeClerck, Y.A., Bone marrow-derived mesenchymal stem cells and the tumor microenvironment (2010) Cancer Metastasis Rev, 29, pp. 249-261

Zhang, T., Lee, Y.W., Rui, Y.F., Cheng, T.Y., Jiang, X.H., Li, G., Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors (2013) Stem Cell Res. Ther, 13, p. 70

Karnoub, A.E., Dash, A.B., Vo, A.P., Sullivan, A., Brooks, M.W., Bell, G.W., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis (2007) Nature, 4, pp. 557-563

Liu, Y., Han, Z.P., Zhang, S.S., Jing, Y.Y., Bu, X.X., Wang, C.Y., Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer (2011) J. Biol. Chem, 15, pp. 25007-25015

Hogan, N.M., Joyce, M.R., Murphy, J.M., Barry, F.P., O'Brien, T., Kerin, M.J., Impact of mesenchymal stem cell secreted PAI-1 on colon cancer cell migration and proliferation (2013) Biochem. Biophys. Res. Commun, 14, pp. 574-579

Ho, I.A., Toh, H.C., Ng, W.H., Teo, Y.L., Guo, C.M., Hui, K.M., Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis (2013) Stem Cells, 31, pp. 146-1455

Cuiffo, B.G., Campagne, A., Bell, G.W., Lembo, A., Orso, F., Lien, E.C., MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis (2014) Cell Stem Cell, 15, pp. 762-774

Related activities ▼
Clinical Oncology (145 views)

Related papers ▼
A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion (restricted access) (83 views)
A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors. (public domain) (9 views)

Related bibliography ▼

Content: [X]

Authors: [X]
AND Paper type: [X]

AND Start date: End date: [X]   AND Site:    AND  IBB affiliation

[Clear form]

<=2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017   ALL YEARS

Sort by: date    title    journal    authors      impact factor

* Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells (20 views)
Pelagalli A, Nardelli A, Fontanella R, Zannetti A
Int J Mol Sci (ISSN: 1422-0067electronic, 1422-0067linking, 1661-6596), 2016 Jul 11; 17(7): N/D-N/D.

View    Export to BibTeX    Export to EndNote    Upload PDF

1 Records (1 excluding Abstracts and Conferences).
Total impact factor: 2.339 (2.339 excluding Abstracts and Conferences).
Total 5-year impact factor: 2.721 (2.721 excluding Abstracts and Conferences).

Your bibliography query: (([btitle, keywords, abstract] BONE AND [btitle, keywords, abstract] MARROW AND [btitle, keywords, abstract] DERIVED AND [btitle, keywords, abstract] MESENCHYMAL AND [btitle, keywords, abstract] STEM AND [btitle, keywords, abstract] CELLS AND [btitle, keywords, abstract] MSCS)) AND NOT [id] = 53039

Last modified by Marco Comerci on Friday 26 May 2017, 12:09:35
404 views. Last viewed on Friday 23 June 2017, 3:29:43

Webmaster and developer: Marco Comerci
For problems and suggestions: adminibb.cnr.it
Last updated: Friday 23 June 2017, 14:42:05